Trademarkia Logo

Canada

C$
Trademark Search in Canada
CIRCLES DESIGN

View On IC.GC.CA

CIRCLES DESIGN
REGISTERED

on 30 Jul 2021

Last Applicant/ Owned by

ARCUTIS BIOTHERAPEUTICS INC.

3027 Townsgate Road, Suite 300Westlake Village, CA 91361

US

Serial Number

1913094 filed on 2th Aug 2018

Registration Number

TMA1105768 registered on 30th Jul 2021

Registration expiry Date

30th Jul 2031

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

CIRCLES DESIGN

Trademark usage description

house mark for a full line of pharmaceutical preparations namely pharmaceuticals for use in dermatology namely dermatitis, skin pigmentation, sexually Read More

Vienna Information

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

Classification Information

Class [005]
House mark for a full line of pharmaceutical preparations namely pharmaceuticals for use in dermatology namely dermatitis, skin pigmentation, sexually transmitted diseases, eczema, psoriasis, skin cancer, acne, immunologic diseases and disorders namely auto immune diseases, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, virology namely human vaccines, oncology, for the treatment of hormonal conditions namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, infertility, sexually transmitted diseases, incontinence and sexual dysfunction, dental diseases, for the treatment of bone disorders and spinal cord systems, neurological disorders namely brain injury, seizure disorders, stroke, Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, psychiatric namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, bipolar disorders, for ophthalmological use; pharmaceutical preparations for use in the diagnosis and treatment of dermatological diseases and disorders namely dermatitis, skin pigmentation, sexually transmitted diseases, eczema, psoriasis, skin cancer, acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, virology namely human vaccines, oncology, for the treatment of hormonal conditions namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, infertility, sexually transmitted diseases, incontinence and sexual dysfunction, dental diseases, for the treatment of bone disorders and spinal cord systems, neurological disorders namely brain injury, seizure disorders, stroke, Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, psychiatric namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, bipolar disorders, ophthalmic conditions for ophthalmological use, and diagnostic reagents for medical use

Classification kind code

11

Class [042]
Product research and development in the field of pharmaceuticals

Classification kind code

11

Mark Details

Serial Number

1913094

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 18th Mar 2021		Approved
Submitted for opposition 15
on 27th Jan 2021		Correspondence Created
Submitted for opposition 135
on 20th Jan 2021		Amendment to Application
Submitted for opposition 135
on 4th Nov 2020		Amendment to Application
Submitted for opposition 22
on 17th Aug 2020		Search Recorded
Submitted for opposition 20
on 17th Aug 2020		Examiner's First Report
Submitted for opposition 135
on 17th Apr 2019		Amendment to Application
Submitted for opposition 31
on 6th Aug 2018		Formalized
Submitted for opposition 1
on 3rd Aug 2018		Created
Submitted for opposition 30
on 2th Aug 2018		Filed